AI Generated
Oct 31, 2026, 11:04
Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A
Abhivandan Nagia, Director at ABNewswire, shared a post on LinkedIn:
“Hemophilia A Clinical Trial Pipeline Gains Momentum: 40 plus Companies Lead the Charge in Pioneering New Treatments | DelveInsight:
The Hemophilia A clinical trial analysis report delivers important insights into ongoing research on 40 plus pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
(Albany, US) On October 29, 2026- DelveInsight’s ‘Hemophilia A Pipeline Insights 2026‘ report provides comprehensive insights… ”
Stay updated with Hemostasis Today.
-
Oct 31, 2026, 12:21Niksa Bagheri: Key Shear Regimes and Physics Selection for Continuum Thrombosis Modeling
-
Oct 31, 2026, 12:14Ghaith Abu-Zeinah: International MPN Congress Honors the Life and Legacy of MPN Pioneer Dr. Richard T. Silver
-
Oct 31, 2026, 12:11Thierry Burnouf: Taipei Medical University and University of Lille Highlight Platelet Biotherapies in SfN Neuronline
-
Oct 31, 2026, 12:07Eamon Faulkner: How Oxygen Shapes Platelet–Endothelial Interactions
-
Oct 31, 2026, 12:01Abdul Mannan: IVIG in ITP – When a Temporary Response Is a Success
-
Oct 31, 2026, 11:52Breaking the Silence Around Bleeding Disorders in Women – National Bleeding Disorders Foundation
-
Oct 31, 2026, 11:21Jim Meliezer: Aspirin May Help Prevent Recurrent Preterm Birth
-
Oct 31, 2026, 11:10Elly De Bruyn: QbD Group Quiz Supports the World Federation of Hemophilia
-
Oct 31, 2026, 10:54Bartosz Puła: New Advances in Hematology Featured in Acta Haematologica Polonica